In addition, BC treatment significantly (p < 0.05) reduced the secreted levels of two growth factors, G-CSF (FC 0.60) and VEGF (FC 0.66); similarly, CSf significantly decreased G-CSF secretion (FC 0.78, p < 0.05) vs. pCTRL (Figure 2b). Here, CSF2 is linked to breast cancer.